Publication: Imatinib mesylate reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukemia
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Şimşek, Eda Tanrıkulu
Eskazan, Ahmet Emre
Cengiz, Mahir
Ar, M. Cem
Ekizoğlu, Seda
Salihoğlu, Ayşe
Gültürk, Emine
Elverdi, Tuğrul
Aydın, Seniz Öngören
Demiröz, Ahu Senem
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Source
Publisher
American Society Hematology
Subject
Citation
item.page.haspartof
Source
Blood
item.page.ispartofseries
item.page.edition
DOI
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A
Collections
Endorsement
Review
Supplemented By
Referenced By
Google Scholar
Scholar'da Ara ↗ Bu yayında DOI yok — Altmetric/Dimensions/PlumX/BIP! rozetleri DOI gerektirir.
